Science Daily: Pharmacology News
FEBRUARY 7, 2025
Researchers have analyzed the soft tissue from a fossilized plesiosaur for the first time. The results show that the long-necked marine reptile had both smooth and scaly skin. This was likely so it could both swim rapidly and move along rough seabeds.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- The Texas Department of State Health Services (DSHS) is reporting an outbreak of measles in Gaines County.All cases have been identified among unvaccinated school-aged children who are residents of Gaines County. Symptom.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
FEBRUARY 7, 2025
An international collaboration sheds new light on the relationship between quantum theory and thermodynamics. The research group demonstrated that while the laws of quantum theory alone do not inherently prevent violations of the second law of thermodynamics, any quantum process can be implemented without actually violating the law. This surprising result suggests a peaceful coexistence between quantum theory and thermodynamics, despite their logical independence.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The group's annual survey of its.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
FEBRUARY 7, 2025
'Temperamental' stars that brighten and dim over a matter of hours or days may be distorting our view of thousands of distant planets, suggests a new study.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
FEBRUARY 7, 2025
Based on the current pledges of countries for limiting their emissions of greenhouse gases, global temperatures are projected to reach 2.7 degrees Celsius beyond pre-industrial levels by the end of this century. A new review paper highlights how this would dramatically reshape the Arctic, the fastest-warming region of Earth.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- Scientists are calling on the U.S. Centers for Disease Control and Prevention (CDC) to disclose data about the risks of bird flu to people and pets that was posted briefly online Wednesday and quickly deleted.The data table.
BioPharma Drive: Drug Pricing
FEBRUARY 7, 2025
“There is not a single member of AAM who has not raised concerns about the tariff situation,” said the CEO of the generic drug lobby Association for Accessible Medicines.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- Heavy weed use may be far more dangerous than people realize, according to a pair of studies published in JAMA Network Open. People diagnosed with cannabis use disorder (CUD) may face nearly triple the risk of death over.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Collaborative Drug
FEBRUARY 7, 2025
Vault Snack #28 - Averting the Sample Apocalypse!
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain relievers when injuries strike.A new study of data from the 2021 and 2022 seasons finds the National.
BioPharma Drive: Drug Pricing
FEBRUARY 7, 2025
The two biotechs, which have lost most of their share value following lucrative IPOs, are combining in a deal that leaves the new company with a bigger cash balance and three drugs in testing.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds.The study involved patients with estrogen receptor positive (ER+)/human epidermal.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioPharma Drive: Drug Pricing
FEBRUARY 7, 2025
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t yet found a suitor and a pair of biotechs cut staff.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- Trauma experienced by the oldest child in a family does not bode well for their younger siblings, new British data suggest.A child's odds for developing mental health issues rose significantly if their oldest sibling.
Quanticate
FEBRUARY 7, 2025
Learn about the proportional odds assumption in clinical trials, its importance in ordinal regression, and key considerations for statistical analysis.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- Los Angeles County residents are still recovering from the devastation of the Palisades and Eaton fires, and new data show that emergency department (ED) visits for wildfire-related issues jumped eight-fold in the days after.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug Channels
FEBRUARY 7, 2025
Todays guest post comes from Richard Faris, Chief Strategy & Growth Officer at PANTHERx Rare Pharmacy. Richard outlines the key factors for commercialization success when a manufacturer launches treatments for rare and orphan diseases. He explains the key considerations for choosing a specialty pharmacy network design, selecting the right pharmacy partners, and establishing patient services HUBs.
Drugs.com
FEBRUARY 7, 2025
FRIDAY, Feb. 7, 2025 -- With Los Angeles still reeling from the devastating Palisades and Eaton fires, a new report on California blazes from earlier years finds the toll on survivors' hearts can be severe. However, the study also found that the.
Perficient: Drug Development
FEBRUARY 7, 2025
One of the biggest things I come across with new and existing clients is a slow website and it impacts engagement, search rankings, and overall business performance. Whether running Sitecore XP or leveraging XM Cloud, optimizing performance is critical to delivering seamless digital experiences. While many assume slow load times stem from back-end inefficiencies, the reality is that both the front-end and back-end play a role in overall site speed.
Metabolite Tales Blog
FEBRUARY 7, 2025
CYP3A-Mediated Metabolism of Suzetrigine By Julia Shanu-Wilson Its been more than 20 years since a pain drug with a new mechanism has been given the go-ahead. As a result theres been much excitement around the recent FDA approval of Vertexs suzetrigine as a first-in-class non-opioid treatment for management of acute pain. Suzetrigine (marketed as Journavx) selectively blocks the Na V 1.8 voltage-gated sodium channel, thereby preventing nerve pulses from the peripheral nervous system from reachin
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Expert insights. Personalized for you.
285 
Let's personalize your content